COLL COLLEGIUM PHARMACEUTICAL, INC
Nasdaq · SEC CIK 1267565 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $7.24M 11 sales by 8 insiders
- Filings on record
- 141 since 2021-07-06, latest 2026-06-10 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Dreyer Scott | EVP, Chief Commercial Off | — | $2.87M |
| Fallon John A. | Dir | — | $1.65M |
| Tupper Colleen | EVP, CFO | — | $1.22M |
| Dieter David | EVP, GC | — | $716.2K |
| BOHLIN GAREN G | Dir | — | $323.5K |
| Balice-Gordon Rita J. | Dir | — | $171.7K |
| Lurker Nancy | Dir | — | $161.9K |
| Freund John Gordon | Dir | — | $143.2K |
| Glancy Donovan Michael | Dir | — | — |
| Smith Thomas B | EVP, Chief Medical Off | — | — |
Transactions 192
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-10 16:10 | 2026-06-08 | COLL | SANTINI GINO | Dir | M - OptEx | $16.49 | +8,700 | 112.5K | +8% | +$143.5K |
| 2026-05-20 16:05 | 2026-05-18 | COLL | Freund John Gordon | Dir | S - Sale | $34.05 | -20 | 84.0K | -0.0% | -$681 | |
| 2026-05-18 16:15 | 2026-05-14 | COLL | Lurker Nancy | Dir | A - Grant | $0.00 | +8,741 | 26.8K | +49% | $0 | |
| 2026-05-18 16:15 | 2026-05-14 | COLL | Paya Carlos V | Dir | A - Grant | $0.00 | +8,741 | 28.3K | +45% | $0 | |
| D | 2026-05-18 16:15 | 2026-05-14 | COLL | Freund John Gordon | Dir | A - Grant | $0.00 | +8,741 | 79.4K | +12% | $0 |
| D | 2026-05-18 16:15 | 2026-05-15 | COLL | Freund John Gordon | Dir | M - OptEx | $16.49 | +8,700 | 88.1K | +11% | +$143.5K |
| D | 2026-05-18 16:15 | 2026-05-15 | COLL | Freund John Gordon | Dir | S - Sale+OE | $34.54 | -4,127 | 84.0K | -5% | -$142.5K |
| 2026-05-18 16:15 | 2026-05-14 | COLL | BOHLIN GAREN G | Dir | A - Grant | $0.00 | +8,741 | 71.0K | +14% | $0 | |
| 2026-05-18 16:15 | 2026-05-14 | COLL | Glancy Donovan Michael | Dir | A - Grant | $0.00 | +17.5K | 17.5K | New | $0 | |
| 2026-05-18 16:15 | 2026-05-14 | COLL | Balice-Gordon Rita J. | Dir | A - Grant | $0.00 | +8,741 | 61.4K | +17% | $0 | |
| 2026-05-18 16:15 | 2026-05-14 | COLL | SANTINI GINO | Dir | A - Grant | $0.00 | +8,741 | 103.8K | +9% | $0 | |
| 2026-05-15 16:05 | 2026-05-13 | COLL | Lurker Nancy | Dir | S - Sale | $35.97 | -4,500 | 18.0K | -20% | -$161.9K | |
| D | 2026-05-13 16:05 | 2026-05-11 | COLL | BOHLIN GAREN G | Dir | M - OptEx | $16.49 | +8,700 | 71.0K | +14% | +$143.5K |
| D | 2026-05-13 16:05 | 2026-05-11 | COLL | BOHLIN GAREN G | Dir | S - Sale+OE | $37.18 | -8,700 | 62.3K | -12% | -$323.5K |
| 2026-04-03 16:46 | 2026-03-17 | COLL | Dieter David | EVP, GC | F - Tax | $35.72 | -8,840 | 68.2K | -11% | -$315.8K | |
| 2026-03-20 | 2026-03-18 | COLL | Dieter David | EVP, GC | S - Sale | $34.92 | -14.0K | 77.1K | -15% | -$488.0K | |
| 2026-03-11 | 2026-03-09 | COLL | Dieter David | EVP, GC | S - Sale | $36.65 | -6,224 | 91.0K | -6% | -$228.1K | |
| M | 2026-03-05 | 2026-03-03 | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $40.40 | -50.0K | 75.3K | -40% | -$2.02M |
| 2026-02-12 | 2026-02-10 | COLL | Karnani Vikram | Pres, CEO, Dir | F - Tax | $46.75 | -11.3K | 197.9K | -5% | -$528.1K | |
| M | 2026-02-12 | 2026-02-10 | COLL | Karnani Vikram | Pres, CEO, Dir | A - Grant | $0.00 | +111.8K | 176.6K | +172% | $0 |
| M | 2026-02-12 | 2026-02-10 | COLL | Tupper Colleen | EVP, CFO | A - Grant | $0.00 | +59.2K | 153.1K | +63% | $0 |
| M | 2026-02-12 | 2026-02-10 | COLL | Tupper Colleen | EVP, CFO | F - Tax | $46.75 | -38.5K | 147.3K | -21% | -$1.80M |
| M | 2026-02-12 | 2026-02-10 | COLL | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $46.75 | -31.6K | 143.4K | -18% | -$1.48M |
| M | 2026-02-12 | 2026-02-10 | COLL | Dreyer Scott | EVP, Chief Commercial Off | A - Grant | $0.00 | +49.7K | 122.6K | +68% | $0 |
| M | 2026-02-12 | 2026-02-10 | COLL | Smith Thomas B | EVP, Chief Medical Off | F - Tax | $46.75 | -17.4K | 90.7K | -16% | -$815.1K |
| M | 2026-02-12 | 2026-02-10 | COLL | Smith Thomas B | EVP, Chief Medical Off | A - Grant | $0.00 | +37.0K | 85.3K | +77% | $0 |
| M | 2026-02-12 | 2026-02-10 | COLL | Dieter David | EVP, GC | A - Grant | $0.00 | +31.2K | 100.1K | +45% | $0 |
| 2026-02-12 | 2026-02-10 | COLL | Dieter David | EVP, GC | F - Tax | $46.75 | -2,781 | 97.3K | -3% | -$130.0K | |
| DM | 2025-12-10 | 2025-12-08 | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale+OE | $48.17 | -17.6K | 103.6K | -15% | -$847.8K |
| D | 2025-12-10 | 2025-12-08 | COLL | Dreyer Scott | EVP, Chief Commercial Off | M - OptEx | $15.90 | +17.6K | 121.2K | +17% | +$279.8K |
| 2025-12-09 | 2025-12-05 | COLL | Balice-Gordon Rita J. | Dir | S - Sale | $47.03 | -3,650 | 52.6K | -6% | -$171.7K | |
| DM | 2025-11-14 | 2025-11-12 | COLL | Fallon John A. | Dir | M - OptEx | $12.41 | +34.9K | 99.5K | +54% | +$432.6K |
| D | 2025-11-14 | 2025-11-12 | COLL | Fallon John A. | Dir | S - Sale+OE | $47.21 | -34.9K | 64.6K | -35% | -$1.65M |
| 2025-11-14 | 2025-11-12 | COLL | Karnani Vikram | Pres, CEO, Dir | F - Tax | $47.35 | -8,983 | 97.0K | -8% | -$425.3K | |
| M | 2025-11-07 | 2025-11-06 | COLL | Tupper Colleen | EVP, CFO | S - Sale | $40.53 | -30.0K | 126.7K | -19% | -$1.22M |
| 2025-09-03 | 2025-08-29 | COLL | Smith Thomas B | EVP, Chief Medical Off | S - Sale | $38.42 | -17.5K | 70.3K | -20% | -$671.5K | |
| D | 2025-08-20 | 2025-08-18 | COLL | Dreyer Scott | EVP, Chief Commercial Off | M - OptEx | $21.34 | +16.4K | 120.0K | +16% | +$349.7K |
| D | 2025-08-20 | 2025-08-18 | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale+OE | $38.21 | -16.4K | 103.6K | -14% | -$626.2K |
| D | 2025-08-19 | 2025-08-15 | COLL | SANTINI GINO | Dir | M - OptEx | $13.45 | +15.0K | 100.4K | +18% | +$201.8K |
| D | 2025-08-19 | 2025-08-15 | COLL | SANTINI GINO | Dir | S - Sale+OE | $37.19 | -5,405 | 95.0K | -5% | -$201.0K |
| D | 2025-08-15 | 2025-08-13 | COLL | Dreyer Scott | EVP, Chief Commercial Off | M - OptEx | $21.34 | +4,861 | 108.5K | +5% | +$103.7K |
| D | 2025-08-15 | 2025-08-13 | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale+OE | $38.03 | -4,861 | 103.6K | -4% | -$184.9K |
| I | 2025-08-15 | 2025-08-13 | COLL | Rubric Capital Management LP | 10% | S - Sale | $37.85 | -25.0K | 3.13M | -0.8% | -$946.2K |
| I | 2025-08-12 | 2025-08-08 | COLL | Freund John Gordon | Dir | S - Sale | $34.36 | -11.7K | 23.1K | -34% | -$400.6K |
| D | 2025-06-11 | 2025-06-09 | COLL | Freund John Gordon | Dir | M - OptEx | $13.45 | +15.0K | 77.3K | +24% | +$201.8K |
| D | 2025-06-11 | 2025-06-09 | COLL | Freund John Gordon | Dir | S - Sale+OE | $30.62 | -6,601 | 70.7K | -9% | -$202.1K |
| 2025-05-19 | 2025-05-15 | COLL | Balice-Gordon Rita J. | Dir | A - Grant | $0.00 | +9,791 | 56.3K | +21% | $0 | |
| 2025-05-19 | 2025-05-15 | COLL | BOHLIN GAREN G | Dir | A - Grant | $0.00 | +9,791 | 62.3K | +19% | $0 | |
| 2025-05-19 | 2025-05-15 | COLL | Fallon John A. | Dir | A - Grant | $0.00 | +9,791 | 64.6K | +18% | $0 | |
| 2025-05-19 | 2025-05-15 | COLL | Freund John Gordon | Dir | A - Grant | $0.00 | +9,791 | 62.3K | +19% | $0 | |
| 2025-05-19 | 2025-05-15 | COLL | Paya Carlos V | Dir | A - Grant | $0.00 | +19.6K | 19.6K | New | $0 | |
| 2025-05-19 | 2025-05-15 | COLL | SANTINI GINO | Dir | A - Grant | $0.00 | +9,791 | 85.4K | +13% | $0 | |
| 2025-05-19 | 2025-05-15 | COLL | Lurker Nancy | Dir | A - Grant | $0.00 | +9,791 | 22.5K | +77% | $0 | |
| M | 2025-03-24 | 2025-03-20+ | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.03 | -20.8K | 122.5K | -15% | -$624.8K |
| M | 2025-03-24 | 2025-03-20+ | COLL | Tupper Colleen | EVP, CFO | S - Sale | $30.03 | -7,602 | 163.1K | -4% | -$228.3K |
| 2025-03-19 | 2025-03-17 | COLL | Dieter David | EVP, GC | A - Grant | $0.00 | +68.4K | 68.4K | New | $0 | |
| 2025-03-18 | 2025-03-14 | COLL | Tupper Colleen | EVP, CFO | S - Sale | $30.00 | -977 | 164.3K | -0.6% | -$29.3K | |
| 2025-03-18 | 2025-03-14 | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.00 | -2,255 | 124.4K | -2% | -$67.7K | |
| A | 2025-03-18 | 2025-03-11 | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.00 | -15.4K | 126.7K | -11% | -$461.6K |
| 2025-03-13 | 2025-03-06 | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.00 | -15.4K | 126.7K | -11% | -$461.6K | |
| 2025-03-13 | 2025-03-11 | COLL | Tupper Colleen | EVP, CFO | S - Sale | $30.01 | -10.4K | 165.2K | -6% | -$313.5K | |
| M | 2025-03-10 | 2025-03-06+ | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.00 | -5,643 | 142.1K | -4% | -$169.3K |
| M | 2025-03-10 | 2025-03-06+ | COLL | Tupper Colleen | EVP, CFO | S - Sale | $30.00 | -3,453 | 177.2K | -2% | -$103.6K |
| DM | 2025-03-06 | 2025-03-04+ | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale+OE | $28.20 | -86.1K | 134.2K | -39% | -$2.43M |
| D | 2025-03-06 | 2025-03-04 | COLL | Kuhlmann Shirley R. | EVP, GC | M - OptEx | $24.03 | +40.0K | 194.2K | +26% | +$961.2K |
| 2025-02-12 | 2025-02-10 | COLL | Heffernan Michael Thomas | Dir | A - Grant | $0.00 | +4,820 | 50.3K | +11% | $0 | |
| M | 2025-02-12 | 2025-02-10 | COLL | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $30.52 | -29.6K | 169.4K | -15% | -$904.1K |
| M | 2025-02-12 | 2025-02-10 | COLL | Dreyer Scott | EVP, Chief Commercial Off | A - Grant | $0.00 | +71.4K | 177.3K | +67% | $0 |
| M | 2025-02-12 | 2025-02-10 | COLL | Smith Thomas B | EVP, Chief Medical Off | F - Tax | $30.52 | -5,897 | 92.1K | -6% | -$180.0K |
| M | 2025-02-12 | 2025-02-10 | COLL | Smith Thomas B | EVP, Chief Medical Off | A - Grant | $0.00 | +39.1K | 88.3K | +79% | $0 |
| M | 2025-02-12 | 2025-02-10 | COLL | Tupper Colleen | EVP, CFO | A - Grant | $0.00 | +78.7K | 182.6K | +76% | $0 |
| M | 2025-02-12 | 2025-02-10 | COLL | Tupper Colleen | EVP, CFO | F - Tax | $30.52 | -30.4K | 201.5K | -13% | -$928.6K |
| M | 2025-02-12 | 2025-02-10 | COLL | Kuhlmann Shirley R. | EVP, GC | F - Tax | $30.52 | -35.0K | 154.2K | -18% | -$1.07M |
| M | 2025-02-12 | 2025-02-10 | COLL | Kuhlmann Shirley R. | EVP, GC | A - Grant | $0.00 | +70.0K | 160.1K | +78% | $0 |
| 2025-02-05 | 2025-02-04 | COLL | Lurker Nancy | Dir | A - Grant | $0.00 | +12.7K | 12.7K | New | $0 | |
| DM | 2025-01-14 | 2025-01-10 | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale+OE | $33.04 | -27.5K | 125.3K | -18% | -$908.6K |
| D | 2025-01-14 | 2025-01-10 | COLL | Kuhlmann Shirley R. | EVP, GC | M - OptEx | $21.34 | +27.5K | 146.7K | +23% | +$586.9K |
| D | 2024-11-14 | 2024-11-12 | COLL | Karnani Vikram | Pres, CEO, Dir | A - Grant | $0.00 | +106.0K | 106.0K | New | $0 |
| 2024-09-17 | 2024-09-13 | COLL | Smith Thomas B | EVP, Chief Medical Off | S - Sale | $36.62 | -9,593 | 53.8K | -15% | -$351.3K | |
| M | 2024-09-06 | 2024-09-05+ | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale | $38.26 | -20.2K | 120.2K | -14% | -$773.8K |
| M | 2024-06-05 | 2024-06-03 | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale | $32.57 | -25.0K | 139.4K | -15% | -$814.2K |
| 2024-05-29 | 2024-05-28 | COLL | Tupper Colleen | EVP, CFO | S - Sale | $34.21 | -19.7K | 130.8K | -13% | -$674.3K | |
| DM | 2024-05-28 | 2024-05-23+ | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale+OE | $33.90 | -108.0K | 138.9K | -44% | -$3.66M |
| DM | 2024-05-28 | 2024-05-23+ | COLL | Dreyer Scott | EVP, Chief Commercial Off | M - OptEx | $24.03 | +75.0K | 190.1K | +65% | +$1.80M |
| 2024-05-16 | 2024-05-16 | COLL | Melincoff Gwen A | Dir | A - Grant | $0.00 | +7,693 | 52.5K | +17% | $0 | |
| 2024-05-16 | 2024-05-16 | COLL | Heffernan Michael Thomas | Dir | A - Grant | $0.00 | +7,693 | 45.5K | +20% | $0 | |
| 2024-05-16 | 2024-05-16 | COLL | Fallon John A. | Dir | A - Grant | $0.00 | +7,693 | 54.8K | +16% | $0 | |
| 2024-05-16 | 2024-05-16 | COLL | SANTINI GINO | Dir | A - Grant | $0.00 | +7,693 | 75.7K | +11% | $0 | |
| 2024-05-16 | 2024-05-16 | COLL | Freund John Gordon | Dir | A - Grant | $0.00 | +7,693 | 52.5K | +17% | $0 | |
| D | 2024-05-16 | 2024-05-14 | COLL | BOHLIN GAREN G | Dir | M - OptEx | $5.73 | +29.0K | 73.8K | +65% | +$166.1K |
| D | 2024-05-16 | 2024-05-16 | COLL | BOHLIN GAREN G | Dir | A - Grant | $0.00 | +7,693 | 52.5K | +17% | $0 |
| D | 2024-05-16 | 2024-05-14 | COLL | BOHLIN GAREN G | Dir | S - Sale+OE | $32.30 | -29.0K | 44.8K | -39% | -$936.2K |
| 2024-05-16 | 2024-05-16 | COLL | McFarlane Neil F. | Dir | A - Grant | $0.00 | +7,693 | 49.4K | +18% | $0 | |
| 2024-05-16 | 2024-05-16 | COLL | Balice-Gordon Rita J. | Dir | A - Grant | $0.00 | +7,693 | 46.5K | +20% | $0 | |
| 2024-03-04 | 2024-02-29 | COLL | Smith Thomas B | EVP, Chief Medical Off | S - Sale | $36.76 | -995 | 63.4K | -2% | -$36.6K | |
| M | 2024-02-28 | 2024-02-26 | COLL | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $36.43 | -10.0K | 138.9K | -7% | -$364.3K |
| M | 2024-02-14 | 2024-02-12 | COLL | Smith Thomas B | EVP, Chief Medical Off | F - Tax | $33.70 | -3,199 | 65.7K | -5% | -$107.8K |
| M | 2024-02-14 | 2024-02-12 | COLL | Smith Thomas B | EVP, Chief Medical Off | A - Grant | $0.00 | +35.4K | 63.0K | +129% | $0 |
| M | 2024-02-14 | 2024-02-12 | COLL | Ciaffoni Joseph | Pres, CEO, Dir | A - Grant | $0.00 | +298.7K | 573.7K | +109% | $0 |
| M | 2024-02-14 | 2024-02-12 | COLL | Ciaffoni Joseph | Pres, CEO, Dir | F - Tax | $33.70 | -128.9K | 526.3K | -20% | -$4.34M |
Purchase Sale Sale after option exercise All abbreviations